Voglibose for prevention of type 2 diabetes mellitus.
Scheen
André J
AJ
Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Liège, B-4000 Liège, Belgium. andre.scheen@chu.ulg.ac.be
D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000517:prevention & control*; D018149:Glucose Intolerance / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007294:Inositol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008019:Life Style; D010353:Patient Education as Topic; D040242:Risk Reduction Behavior
D007004:Hypoglycemic Agents; D007294:Inositol; C102817:voglibose